ORPHAZYME A/S - ADR (ORPH) Stock Analyst Ratings
NASDAQ:ORPH - Nasdaq - ADR
ChartMill assigns a Buy % Consensus number of 38% to ORPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.81. This target is 1717.72% above the current price.
ORPH was analyzed by 9 analysts. The buy percentage consensus is at 38. So analysts seem to be rather negative about ORPH.
In the previous month the buy percentage consensus was at a similar level.
ORPH was analyzed by 9 analysts. More opinions would make the average more meaningful.